NASDAQ
CYduct Diagnostics, Inc. (CYDX) has a price/sales ratio of 18.69x as of Friday, May 22, 2026. This represents a 10.72% increase compared to its 12-month average of 16.88x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.